THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND)

The Global Fund to Fight AIDS, Tuberculosis and Malaria is a multilateral financing institution dedicated to mobilizing and deploying resources to combat three of the world’s most devastating infectious diseases. Its core capabilities center on global health financing, program design, and results-based funding mechanisms for country-led responses. The organization works with governments, civil society, and international partners to strengthen health systems, procure essential medicines and diagnostics, and scale up prevention and treatment services in high-burden regions. Technical expertise includes epidemiological modeling, supply chain optimization for antiretrovirals and antimalarials, performance-based financing, and data-driven monitoring and evaluation frameworks aligned with global health standards. Its unique differentiator lies in its ability to coordinate multi-stakeholder partnerships across low- and middle-income countries, ensuring funding aligns with national health priorities and global targets. No contract award history is available to inform agency-specific engagement patterns or procurement relationships with U.S. government entities. Consequently, no direct agency experience can be inferred from the provided data. No NAICS codes are associated with the organization’s award history, indicating that its operations fall outside the scope of traditional U.S. federal contracting categories. Its work is primarily conducted through international development channels and global health partnerships rather than domestic government procurement. The organization is structured as an independent public-private partnership with headquarters in Switzerland and a global operational footprint. It does not hold U.S. government certifications such as 8(a), HUBZone, or SDVOSB, and its market positioning is not within the U.S. federal contracting landscape but rather in the domain of international development finance and global health governance.